Search Results - "Melnyk, Anton"
-
1
Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer: The Hoosier Oncology Group and U.S. Oncology
Published in Journal of clinical oncology (10-12-2008)“…Concurrent chemoradiotherapy is standard treatment for patients with inoperable stage III non-small-cell lung cancer (NSCLC). A phase II study by the Southwest…”
Get full text
Journal Article -
2
Polaron spin dynamics in high-mobility polymeric semiconductors
Published in Nature physics (01-08-2019)“…Polymeric semiconductors exhibit exceptionally long spin lifetimes, and recently observed micrometre spin diffusion lengths in conjugated polymers demonstrate…”
Get full text
Journal Article -
3
Practical Synthetic Method for Functionalized 1‑Methyl-3/5-(trifluoromethyl)‑1H‑pyrazoles
Published in Organic process research & development (20-11-2020)“…A new, high-yielding, and practical method for synthesis of 1-methyl-3-(trifluoromethyl)-1H-pyrazole and 1-methyl-5-(trifluoromethyl)-1H-pyrazole, key…”
Get full text
Journal Article -
4
Gemcitabine, Cisplatin, and Sunitinib for Metastatic Urothelial Carcinoma and as Preoperative Therapy for Muscle-Invasive Bladder Cancer
Published in Clinical genitourinary cancer (01-06-2013)“…Micro-Abstract Parallel trials in advanced disease and neoadjuvant settings are attractive for accelerating drug development in bladder cancer. However, the…”
Get full text
Journal Article -
5
Preparation of 5-Fluoropyrazoles from Pyrazoles and N-Fluorobenzenesulfonimide (NFSI)
Published in Journal of organic chemistry (16-03-2018)“…Facile synthesis of 5-fluoropyrazoles by direct fluorination of pyrazoles with N-fluorobenzenesulfonimide (NFSI) was elaborated. This approach was used to…”
Get full text
Journal Article -
6
Phase I Trial of “bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell” Vaccine (FANG) in Advanced Cancer
Published in Molecular therapy (01-03-2012)“…We performed a phase I trial of FANG vaccine, an autologous tumor-based product incorporating a plasmid encoding granulocyte-macrophage colony-stimulating…”
Get full text
Journal Article -
7
Solid-State Electron Affinity Analysis of Amorphous Fluorinated Polymer Electret
Published in The journal of physical chemistry. B (19-11-2020)“…In this study, electron trapping phenomena in amorphous polymer electrets were studied using a solid-state electron affinity analysis by means of molecular…”
Get full text
Journal Article -
8
Generic Model for Lamellar Self-Assembly in Conjugated Polymers: Linking Mesoscopic Morphology and Charge Transport in P3HT
Published in Macromolecules (12-02-2019)“…We develop a generic coarse-grained model of soluble conjugated polymers, capable of describing their self-assembly into a lamellar mesophase. Polymer chains…”
Get full text
Journal Article -
9
A Methodical Approach to the Assessment of Organizational Culture
Published in Bìznes ìnform (Multilingual ed.) (01-06-2021)“…The article is concerned with substantiating a methodical approach to the assessment of organizational culture. In today’s business environment, organizational…”
Get full text
Journal Article -
10
Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA -Mutant Cancers
Published in Clinical cancer research (15-01-2021)“…Somatic mutations in phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha ( ), which encodes the p110α catalytic subunit of PI3K, are found…”
Get full text
Journal Article -
11
Macroscopic Structural Compositions of π‑Conjugated Polymers: Combined Insights from Solid-State NMR and Molecular Dynamics Simulations
Published in The journal of physical chemistry letters (07-09-2017)“…Molecular dynamics simulations are combined with solid-state NMR measurements to gain insight into the macroscopic structural composition of the π-conjugated…”
Get full text
Journal Article -
12
Phase I trial of "bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell" vaccine (FANG) in advanced cancer
Published in Molecular therapy (01-03-2012)“…We performed a phase I trial of FANG vaccine, an autologous tumor-based product incorporating a plasmid encoding granulocyte-macrophage colony-stimulating…”
Get full text
Journal Article -
13
Long-term followup of bi-shRNA furin and GMCSF augmented autologous tumor cell immunotherapy treated colorectal cancer patients in phase I and IIa studies
Published in Journal of clinical oncology (20-05-2017)“…Abstract only e15100 Background: Vigil is an immuno-stimulatory autologous tumor cell therapy, which uses patient tumor cells transfected with a plasmid…”
Get full text
Journal Article -
14
Long-term follow-up of DNA engineered bi-shRNA furin GMCSF plasmid/autologous tumor induced immune response in patients with advanced solid tumors (phase I trial)
Published in Journal of clinical oncology (01-03-2017)“…Abstract only 110 Background: Previously we described safety and evidence of activity to Vigil Ò (FANG Ò ) and identified relationship of survival advantage to…”
Get full text
Journal Article -
15
Evaluation of Miracle Mouthwash plus Hydrocortisone Versus Prednisolone Mouth Rinses as Prophylaxis for Everolimus‐Associated Stomatitis: A Randomized Phase II Study
Published in The oncologist (Dayton, Ohio) (01-09-2019)“…Background Mammalian target of rapamycin (mTOR) inhibitor‐associated stomatitis (mIAS) is a frequent adverse event (AE) associated with mTOR inhibitor therapy…”
Get full text
Journal Article -
16
Practical Synthetic Method for Functionalized 1-Methyl-3/5-(trifluoromethyl)-1 H -pyrazoles
Published in Organic process research & development (20-11-2020)Get full text
Journal Article -
17
Abstract CT046: A phase I basket study of the PI3K inhibitor taselisib (GDC-0032) in PIK3CA -mutated locally advanced or metastatic solid tumors
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Background: PIK3CA, a gene that encodes the α-isoform of the catalytic subunit of Class I PI3K (PI3Kα), is frequently mutated or amplified in solid…”
Get full text
Journal Article -
18
First interim exploratory analysis of immune response in patients with advanced non-small cell lung cancer receiving viagenpumatucel-l (HS-110) in combination with low-dose cyclophosphamide in an ongoing phase II trial
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article -
19
Phase I evaluation of the PI3 kinase (PI3K) inhibitor taselisib (GDC-0032) in multiple locally advanced or metastatic PIK3CA mutant solid tumor types
Published in Journal of clinical oncology (20-05-2016)“…Abstract only…”
Get full text
Journal Article -
20
Phase I Trial of "bi-shRNAi super(furin)/GMCSF DNA/ Autologous Tumor Cell" Vaccine (FANG) in Advanced Cancer
Published in Molecular therapy (01-03-2012)“…We performed a phase I trial of FANG vaccine, an autologous tumor-based product incorporating a plasmid encoding granulocyte-macrophage colony-stimulating…”
Get full text
Journal Article